🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This laboratory study is looking into biomarkers in samples from younger pa...
Status
Completed
Location
Children's Oncology Group
Start Date
2012-08
Trial ID
NCT01642121
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
This phase II trial tests the effect of total marrow and lymphoid irradiati...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-05
Trial ID
NCT07582172
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
2000-11
Trial ID
NCT00006363
This study involves the use of a drug called Thymoglobulin, which is approv...
Status
Completed
Location
University of Alabama-Birmingham Hospital
Start Date
2004-03
Trial ID
NCT00088543
The main objective of the study is to evaluate the efficacy and safety of m...
Status
Recruiting
Location
Shanghai Jiao Tong University School of Medicine Affilated Shanghai General Hospital
Start Date
2023-01-01
Trial ID
NCT05841771
Treatments Being Tested
This phase II trial is studying the side effects and how well decitabine wo...
Status
Completed
Location
UCSF Medical Center-Mount Zion
Start Date
2006-11-15
Trial ID
NCT00416598
This is a retrospective and prospective non-interventional multicenter obse...
Status
Recruiting
Location
IRCCS Ospedale San Raffaele
Start Date
2022-07-18
Trial ID
NCT05124288
Treatments Being Tested
This phase I/II trial studies the side effects of laboratory-treated T cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2012-12-06
Trial ID
NCT01640301